These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15626313)

  • 1. [Linezolid, an agent from a new class of antibiotics].
    Slebos DJ; Van Altena R
    Ned Tijdschr Geneeskd; 2004 Dec; 148(49):2462; author reply 2462-3. PubMed ID: 15626313
    [No Abstract]   [Full Text] [Related]  

  • 2. [Linezolid, an agent from a new class of antibiotics].
    Kuijper EJ; Schippers EF; Bernards AT
    Ned Tijdschr Geneeskd; 2004 Aug; 148(32):1577-81. PubMed ID: 15382556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis.
    Nam HS; Koh WJ; Kwon OJ; Cho SN; Shim TS
    Int J Antimicrob Agents; 2009 Jan; 33(1):92-3. PubMed ID: 18789655
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful long-term treatment with linezolid for disseminated infection with multiresistant Nocardia farcinica.
    Rivero A; García-Lázaro M; Pérez-Camacho I; Natera C; del Carmen Almodovar M; Camacho A; Torre-Cisneros J
    Infection; 2008 Aug; 36(4):389-91. PubMed ID: 18629435
    [No Abstract]   [Full Text] [Related]  

  • 5. Early linezolid-associated lactic acidosis in a patient treated for tuberculous spondylodiscitis.
    Scotton P; Fuser R; Torresan S; Carniato A; Giobbia M; Rossi C; Inojosa WO; Vaglia A
    Infection; 2008 Aug; 36(4):387-8. PubMed ID: 18642110
    [No Abstract]   [Full Text] [Related]  

  • 6. [Linezolid: antibacterial activity, clinical efficacy and resistance].
    Bourgeois-Nicolaos N; Piriou O; Butel MJ; Doucet-Populaire F
    Ann Biol Clin (Paris); 2006; 64(6):549-64. PubMed ID: 17162258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linezolid resistance in coagulase-negative staphylococci.
    Kelly S; Collins J; Davin M; Gowing C; Murphy PG
    J Antimicrob Chemother; 2006 Oct; 58(4):898-9; author reply 899-900. PubMed ID: 16854956
    [No Abstract]   [Full Text] [Related]  

  • 8. Linezolid resistant enterococcus faecium.
    McNicholas S; Hanahoe B; Higgins F; McAnena O; Corbett-Feeney G; Cormican M
    Ir Med J; 2008; 101(7):225-6. PubMed ID: 18810787
    [No Abstract]   [Full Text] [Related]  

  • 9. [The analysis of clinical data about the treatment of linezolid against tuberculosis].
    Nie WJ; Chu NH
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):601-3. PubMed ID: 24252739
    [No Abstract]   [Full Text] [Related]  

  • 10. [Linezolid for pediatric infections].
    Moulin F; Hériveaux B; Vallet C
    Arch Pediatr; 2010 Jun; 17(6):762-3. PubMed ID: 20654880
    [No Abstract]   [Full Text] [Related]  

  • 11. What is the place of teicoplanin and linezolid in the treatment of prosthetic joint infections?
    Tattevin P; Arvieux C; Michelet C
    Clin Microbiol Infect; 2006 Dec; 12(12):1241-2. PubMed ID: 17121636
    [No Abstract]   [Full Text] [Related]  

  • 12. Experience with linezolid therapy in children with osteoarticular infections.
    Chen CJ; Chiu CH; Lin TY; Lee ZL; Yang WE; Huang YC
    Pediatr Infect Dis J; 2007 Nov; 26(11):985-8. PubMed ID: 17984803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections.
    Brickner SJ; Barbachyn MR; Hutchinson DK; Manninen PR
    J Med Chem; 2008 Apr; 51(7):1981-90. PubMed ID: 18338841
    [No Abstract]   [Full Text] [Related]  

  • 14. Linezolid in the treatment of 'difficult' multidrug-resistant tuberculosis.
    Yew WW; Chau CH; Wen KH
    Int J Tuberc Lung Dis; 2008 Mar; 12(3):345-6. PubMed ID: 18284844
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid.
    Wareham DW; Abbas H; Karcher AM; Das SS
    J Infect; 2006 Apr; 52(4):300-4. PubMed ID: 16099052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Linezolid and tuberculosis, a new and useful treatment].
    Sequi Canet JM; Bernal Ferrer A; Sala Langa MJ
    An Pediatr (Barc); 2008 Mar; 68(3):306-7. PubMed ID: 18358149
    [No Abstract]   [Full Text] [Related]  

  • 17. Glycopeptide insensitive Staphylococcus aureus subdural empyema treated with linezolid and rifampicin.
    Gallagher RM; Pizer B; Ellison JA; Riordan FA
    J Infect; 2008 Nov; 57(5):410-3. PubMed ID: 18703232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection.
    Seedat J; Zick G; Klare I; Konstabel C; Weiler N; Sahly H
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4217-9. PubMed ID: 16982791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroquinolones and linezolid.
    Escribano I; Rodríguez JC; Llorca B; García-Pachon E; Ruiz M; Royo G
    Chemotherapy; 2007; 53(6):397-401. PubMed ID: 17934259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)--a report of ten cases.
    von der Lippe B; Sandven P; Brubakk O
    J Infect; 2006 Feb; 52(2):92-6. PubMed ID: 15907341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.